ArticleJournal of neuroinflammation2026
Structural and functional modifications of neuronal lipid rafts: implications for HIV-associated neurological disorders.
Article in Journal of neuroinflammation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
backgroundHIV-associated neurological disorders (HAND) remain a prevalent co-morbidity of HIV infection. Growing evidence implicates the HIV protein Nef in this process, as Nef increases the abundance of neuronal lipid rafts - cholesterol- and sphingolipid-rich membrane microdomains linked to neurodegeneration and neuroinflammation. Because Nef is released from infected glial cells in extracellular vesicles (exNef), we investigated whether glia-derived exNef alters the structural and functional properties of neuronal lipid rafts in a manner that could contribute to HAND pathogenesis.
methodsA comprehensive lipidomics and proteomics analysis of lipid rafts isolated from cultured human neuronal cell line SH-SY5Y, combined with assessment of biophysical and physiological properties of the rafts, was performed. We compared our findings with existing transcriptomics profiles of brain neurons from individuals diagnosed with HAND.
resultsLipidomics analysis of isolated neuronal lipid raft fractions revealed minimal impact of exNef on the raft lipid composition; physico-chemical properties of the lipid rafts were also unaffected. In contrast, proteomic analysis revealed that among raft proteins with increased abundance following exNef exposure ~25% were implicated in neurological disease pathways. Targeted protein analysis unveiled that exNef promotes the redistribution of several neurodegenerative and inflammatory proteins to the lipid rafts, resulting in increased inflammation and apoptosis alongside reduced neuronal excitability. Pharmacological disruption of raft elevation with the lipid raft antagonist Oxy210 reversed exNef-induced raft expansion and abrogated these structural and functional alterations. Importantly, changes in raft protein composition showed strong concordance with transcriptomic profiles from single-nucleus RNA sequencing (snRNA-seq) of brain from people living with HIV.
conclusionsExNef reorganize the neuronal lipid raft proteome, enhancing the activity of neurodegenerative and inflammatory mediators. This phenomenon may potentially contribute to HAND pathogenesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.